Author: Brian L. Hoh, MD, MBA
Clinical guidelines are important to every neurosurgeon as they identify best practices in neurosurgery based on scientific and clinical evidence. Guidelines improve patient outcomes and safety,and therefore are essential to the practice of all neurosurgeons.
The CNS maintains an in-house infrastructure to lead, promote, and support the creation and methodological processes to produce evidence-based guidelines, working closely with specialty sections from initiation through endorsement and publication. Using a high quality, methodologically robust, and transparent process that combines research, clinician expertise, and patient preferences, the CNS develops clinical guidelines on an ongoing basis.
Augmenting the CNS’s dedication to remaining at the forefront of guideline production, the 2016 CNS Annual Meeting in San Diego will highlight three timely new clinical guidelines updates for neurosurgeons. Three afternoon sessions are dedicated to cover guidelines that are soon-to-bepublished, and guidelines that every neurosurgeon should know. We’re also excited to announce that the authors of each of the guidelines will be in attendance and presenting the guideline recommendations, as well as facilitating discussion.
On Monday, September 26, 2:15–3:15 pm, the soon-to-be-published update on Guidelines for the Management of Traumatic Brain Injury will be presented and discussed. There are a number of controversies in the management of TBI, notably the role of ICP monitoring based on recent clinical trials. These questions, along with the most up-to-date guideline recommendations, will be discussed in relationship to ICP monitoring, hypothermia, ventilation, blood pressure, thresholds, and the prevention and management of deep venous thrombosis. Every neurosurgeon that takes call or takes care of trauma patients will need to know these guidelines.
The session on Guidelines for the Management of Brain Metastases will be presented on Tuesday, September 27, 2:15–3:15 pm. Since the publication of the original guidelines six years ago, there have been advances in treatment and emerging therapies for brain metastases. These new therapies, controversies, and questions regarding the management of brain metastases, including the role of whole brain radiation, surgical resection, retreatment, emerging therapies, chemotherapy, prophylactic anticonvulsants, prophylactic steroids, and stereotactic radiation, will be discussed. The soon-to-be-published guideline recommendations will be presented by the authors so that participants will be up-to-date on the most current best practices.
Every neurosurgeon that takes call or takes care of patients with thoracolumbar spine trauma will want to attend the Guidelines for the Management of Thoracolumbar Fractures session on Wednesday, September 28, 2:15–3:15 pm. The authors of these guidelines will discuss controversies regarding the management of thoracolumbar spine trauma and will present the most current guideline recommendations including the medical management of fractures, operative versus nonoperative treatment, timing of surgical intervention, surgical approaches, and novel surgical strategies.
Take advantage of this fantastic opportunity to attend these timely new guidelines sessions relevant to your practice, and ask questions directly to the authors that wrote these guidelines. See you in San Diego!
THERE ARE A NUMBER OF CONTROVERSIES IN THE MANAGEMENT OF TBI, NOTABLY THE ROLE OF ICP MONITORING BASED ON RECENT CLINICAL TRIALS.